Clinicopathological study of the colorectal mucinous carcinomas

International Surgery

Volumn 91, Issue 6, 2006, Pages 352-357

  Goi, Takanori ^a   Obata, Shinsuke ^a   Inoue, Takeshi ^a   Fujioka, Masako ^a   Hirono, Yasuo ^a   Katayama, Kanji ^a   Yamaguchi, Akio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Colorectal mucinous cancer; E cadherin; Matrix metalloprotease 9; Mucocellular type; Papillotubular type

Indexed keywords

ARTICLE; CLASSIFICATION; COLLOID CARCINOMA; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; PATHOLOGY;

ADENOCARCINOMA, MUCINOUS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 33846354212     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Umpleby HG, Ranson DL, Williamson RCN. Peculiarities of mucinous colorectal carcinoma. Br J Surg 1985;72:715-718
2. Kawashima H, Murakami Y, Kamada H, Takanashi S, Ishigooka M, Hara T et al. Clinicopathological studies of colorectal mutinous carcinomas. J Jpn Surg Assoc 1995;56:1799-1805
3. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000;75:103-107
4. Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 2003;46:160-167
5. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/ collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 1994;91:4293-4297
6. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993;53: 5365-5369
7. Kawashima A, Nakanishi I, Tsuchiya H, Roessner A, Obata K, Okada Y. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch 1994;424:547-552
8. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56:190-196
9. Fleming ID, Cooper JS, Henson DE, Hunter RVP, Kennedy BJ, Murphy GP et al. AJCC Cancer Staging Manual, 5th edn. Philadelphia, PA: Lippincott-Raven, 1997
10. Iwakawa K, Kadota K, Kiyochi H, Matsuda R, Kobayashi N. Clinicopathological study of mucinous carcinomas of the large intestine. Jpn J Gastroenterol Surg 1994;27:1949-1953
11. Goi T, Yamaguchi A, Nakagawara G, Urano T, Shiku H, Furukawa K. Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer 1998;77:466-471
12. Toyota K, Okajima M, Asahara T, Masaoka Y, Kobayashi R, Ojima Y et al. Mucinous carcinoma of the colon and rectum. J Jpn Soc Coloproctol 1994;47:324-330
13. Tanaka S, Ohshita Y, Fukata D. Clinicopathological studies of mucinous carcinoma of the colon and rectum. J Jpn Surg Assoc 1992;53:1088- 1092
14. Morita T, Fujii H, Yamamoto K, Ishikawa H, Yoshikawa S, Nishikawa T et al. A clinicopathological study of the colorectal mucinous carcinoma. J Jpn Surg Assoc 1995;56:2290-2295
15. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891-1900
16. Cho M, Dahiya R, Choi R, Siddiki B, Yeh MM, Sleisenger MH et al. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma. Eur J Can 1997;33:931-941